Literature DB >> 11561557

Gastrointestinal transit in nonobese diabetic mouse: an animal model of human diabetes type 1.

M El-Salhy1.   

Abstract

Gastrointestinal transit (GI) in the nonobese diabetic (NOD) mouse, an animal model of human diabetes type 1, was examined in animals with short- (duration 1-5 days) and long-term (duration 28-35 days) diabetes. Blood glucose level, serum insulin concentration, and gut neuroendocrine peptide content were also measured. GI was significantly rapid in NOD mice with long-term diabetes (LTD), but was not correlated with blood glucose level, serum insulin concentration, or pancreatic insulin content. GI was correlated with duodenal secretin content, but not with the content of other neuroendocrine peptides in the different segments investigated. Whereas antral vasoactive intestinal peptide (VIP) content in NOD mice with LTD was significantly higher, colonic VIP was lower in NOD mice with short-term diabetes (STD). In the duodenum, whereas the concentration of secretin in NOD mice with both STD and LTD was lower, the gastrin content was higher. Duodenal somatostatin content in NOD mice with LTD was lower. In colon, the content of galanin in NOD mice with LTD was higher than in controls. The decreased content of secretin may be among the factors that cause rapid GI in NOD mice with LTD. Changes in the antral content of VIP, duodenal somatostatin, and colonic galanin in NOD mice with LTD may cause low intestinal secretion and, together with rapid GI, give rise to diarrhoea, which is a common symptom in diabetes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11561557     DOI: 10.1016/s1056-8727(01)00158-1

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  11 in total

Review 1.  Upper gastrointestinal sensory-motor dysfunction in diabetes mellitus.

Authors:  Jingbo Zhao; Jens Brøndum Frøkjaer; Asbjørn Mohr Drewes; Niels Ejskjaer
Journal:  World J Gastroenterol       Date:  2006-05-14       Impact factor: 5.742

Review 2.  Cellular pathogenesis of diabetic gastroenteropathy.

Authors:  T Ordög; Y Hayashi; S J Gibbons
Journal:  Minerva Gastroenterol Dietol       Date:  2009-09

Review 3.  Diabetes and the enteric nervous system.

Authors:  B Chandrasekharan; S Srinivasan
Journal:  Neurogastroenterol Motil       Date:  2007-10-17       Impact factor: 3.598

4.  Changes of phasic and tonic smooth muscle function of jejunum in type 2 diabetic Goto-Kakizaki rats.

Authors:  Jing-Bo Zhao; Peng-Min Chen; Hans Gregersen
Journal:  World J Diabetes       Date:  2013-12-15

Review 5.  The role of peptide YY in gastrointestinal diseases and disorders (review).

Authors:  Magdy El-Salhy; Tarek Mazzawi; Doris Gundersen; Jan Gunnar Hatlebakk; Trygve Hausken
Journal:  Int J Mol Med       Date:  2012-12-21       Impact factor: 4.101

Review 6.  Gastrointestinal neuroendocrine peptides/amines in inflammatory bowel disease.

Authors:  Magdy El-Salhy; Tefera Solomon; Trygve Hausken; Odd Helge Gilja; Jan Gunnar Hatlebakk
Journal:  World J Gastroenterol       Date:  2017-07-28       Impact factor: 5.742

Review 7.  Diabetes-induced mechanophysiological changes in the small intestine and colon.

Authors:  Mirabella Zhao; Donghua Liao; Jingbo Zhao
Journal:  World J Diabetes       Date:  2017-06-15

8.  Interdependency between mechanical parameters and afferent nerve discharge in remodeled diabetic Goto-Kakizaki rat intestine.

Authors:  Jingbo Zhao; Jian Yang; Donghua Liao; Hans Gregersen
Journal:  Clin Exp Gastroenterol       Date:  2017-12-01

9.  Changes in expression of inhibitory substances in the intramural neurons of the stomach following streptozotocin- induced diabetes in the pig.

Authors:  Michał Bulc; Katarzyna Palus; Łukasz Zielonka; Magdalena Gajęcka; Jarosław Całka
Journal:  World J Gastroenterol       Date:  2017-09-07       Impact factor: 5.742

10.  Effect of Streptozotocin-Inducted Diabetes on the Pathophysiology of Enteric Neurons in the Small Intestine Based on the Porcine Diabetes Model.

Authors:  Michał Bulc; Jarosław Całka; Katarzyna Palus
Journal:  Int J Mol Sci       Date:  2020-03-17       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.